In this study we primarily aimed to perform a comprehensive analysis on the prognostic role of PIK3CA CN gain with co-occurring PIK3CA mutations in well characterized and publicly available datasets of patients with HR + /HER2− BC. The gene discussed is ERBB2; the disease is breast cancer.